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antinociceptive effects in mouse models of acute
and chronic pain
Julie K Hurt1 and Mark J Zylka1,2*Abstract
Acupuncture has been used for millennia to treat pain, although its efficacy and duration of action is limited.
Acupuncture also has brief (1–2 h) antinociceptive effects in mice and these effects are dependent on localized
adenosine A1 receptor (A1R) activation. Intriguingly, adenosine 5’-monophosphate (AMP) is basally elevated near
acupuncture points. This finding suggested that it might be possible to inhibit nociception for a longer period of
time by injecting prostatic acid phosphatase (PAP, ACPP) into acupuncture points. PAP is an ectonucleotidase that
dephosphorylates extracellular AMP to adenosine, has a long half-life in vivo and is endogenously found in muscle
tissue surrounding acupuncture points. Here, we found that injection of PAP into the popliteal fossa—a space
behind the knee that encompasses the Weizhong acupuncture point—had dose- and A1R-dependent
antinociceptive effects in mouse models of acute and chronic pain. These inhibitory effects lasted up to six days
following a single injection, much longer than the hour-long inhibition provided by acupuncture. Antinociception
could be transiently boosted with additional substrate (AMP) or transiently blocked with an A1R antagonist or an
inhibitor of phospholipase C. This novel therapeutic approach—which we term “PAPupuncture”—locally inhibits
pain for an extended period of time (100x acupuncture), exploits a molecular mechanism that is common to
acupuncture, yet does not require acupuncture needle stimulation.
Keywords: Prostatic acid phosphatase, Adenosine A1 receptor, Acupuncture, Nociception, Ectonucleotidase,
Popliteal fossa, Regional anesthesia, Phospholipase CBackground
Acupuncture is a labor-intensive technique that entails in-
sertion of fine gauge needles into specific locations of the
body followed by intermittent manual rotation or electrical
stimulation of the needles [1]. Essentially all acupuncture
points are located in muscle and are in close proximity to
peripheral nerves [2]. The axons of nociceptive (“pain-
sensing”) neurons course through peripheral nerves [3-5].
This proximity of acupuncture points to nociceptive affer-
ents could explain why acupuncture is modestly effective
at treating pain in humans [1,6-8].
Recently, Goldman and colleagues found that the anti-
nociceptive effects of acupuncture in mice were dependent* Correspondence: zylka@med.unc.edu
1Department of Cell and Molecular Physiology, UNC Neuroscience Center,
The University of North Carolina at Chapel Hill, CB #7545, Chapel Hill, NC
27599, USA
2The University of North Carolina at Chapel Hill, CB# 7545, 115 Mason Farm
Road, Chapel Hill, NC 27599-7545, USA
© 2012 Hurt and Zylka; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the oron the localized activation of A1R [9]. Intriguingly, extra-
cellular AMP concentration was basally elevated near the
Zusanli acupuncture point prior to needle stimulation [9],
indicating a pool of AMP was present under baseline con-
ditions. Manual stimulation of the acupuncture needle
produced further increases in AMP concentration. In light
of these findings, we reasoned that it might be possible to
generate additional adenosine and activate A1R in the
vicinity of acupuncture points by injecting an enzyme that
hydrolyzes AMP to adenosine.
We previously found that the transmembrane isoform of
prostatic acid phosphatase (PAP) functions as an ectonu-
cleotidase and hydrolyzes extracellular AMP to adenosine
in nociceptive dorsal root ganglia neurons [10,11]. PAP is
expressed in several other tissues, including skeletal
muscle that surrounds the Zusanli acupuncture point, and
could be the rate-limiting ectonucleotidase at this location
[9,12]. PAP is a very stable enzyme when administeredal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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found that intrathecal injection of a secretory version of
human PAP (hPAP) had long-lasting (3 days), A1R-
dependent antinociceptive effects in pre-clinical models of
inflammatory pain and neuropathic pain [10,14]. These
long-lasting antinociceptive effects could be transiently
blocked with a short-acting A1R antagonist, providing
strong evidence that hPAP remains in tissue for days
[10,15]. In contrast, adenosine has a very short half-life in
blood (a few seconds) [16]. hPAP injections thus provide a
novel way to generate a short-acting compound over a sus-
tained time period [17].
Here, we sought to determine if the adenosine receptor
dependent antinociceptive effects of acupuncture could
be exploited and greatly extended by injecting hPAP into
an acupuncture point. When combined with a recombin-
ant version of hPAP [18], this approach could be utilized
to more effectively treat chronic pain in localized regions
of the body without acupuncture needle stimulation.
Results
The Weizhong acupuncture point, located behind the
knee within the popliteal fossa (Figure 1A), is com-
monly needled by acupuncturists to treat pain [7,19].
Clinicians inject local anesthetics into this same loca-
tion for regional anesthesia [20,21]. Since A1R activa-
tion in peripheral tissues, including at the Zusanli
acupuncture point (which is anatomically close to
Weizhong; Figure 1A’), had brief antinociceptive effects
in rodents [9,22-25], we first sought to determine if
A1R activation at Weizhong also had antinociceptive
effects. To test this, we injected a selective A1R agonist,
N6-cyclopentyladenosine (CPA), into the popliteal fossa
of wild-type mice and A1R
−/− mice while monitoring
noxious thermal and mechanical sensitivity. We found
that CPA transiently (2 hr) inhibited noxious thermal
sensitivity in the ipsilateral hindpaw of wild-type mice
but did not affect thermal sensitivity in the contralateral
hindpaw (Figure 1B). In contrast, CPA had no effect in
either hindpaw of A1R
-/- mice (Figure 1B). Additionally,
CPA did not affect mechanical sensitivity in naïve (non-
sensitized) wild-type or A1R
−/− mice (Figure 1C). Lastly,
vehicle injection did not affect thermal or mechanical
sensitivity (Figure 1D,E). Taken together, these data re-
veal that activation of A1R at the Weizhong acupunc-
ture point can locally inhibit nociception.
Goldman and colleagues recently found that the concen-
tration of AMP was elevated relative to other nucleotides
near the Zusanli acupuncture point [9]. Extracellular AMP
is also basally elevated in human muscle [26], the tissue
where acupuncture points are located [2]. Given our previ-
ous work with PAP—an ectonucleotidase that hydrolyzes
AMP to adenosine and activates A1R for days following a
single spinal injection [10,14,15,17]—we hypothesized itmight be possible to enzymatically hydrolyze the pool of
AMP to adenosine and inhibit nociception without per-
forming acupuncture. To test this, we injected hPAP pro-
tein into the popliteal fossa—a novel approach we call
“PAPupuncture”—then monitored noxious thermal and
mechanical sensitivity in the hindpaw. Strikingly, injection
of hPAP (250 mU) into the popliteal fossa inhibited ther-
mal sensitivity for three days only in the injected leg of
wild-type mice (Figure 2A). This localized effect contrasts
with spinal injections, which target both legs, and systemic
drug injections that target the entire body. Importantly,
hPAP did not affect thermal sensitivity in A1R
−/− mice,
demonstrating a critical requirement for A1R activation
(Figure 2A). In addition, hPAP did not affect mechanical
sensitivity in naïve mice (Figure 2B). Increased withdrawal
latency in the thermal assay was not due to motor impair-
ment, as the same dose of hPAP did not affect motor func-
tion in the rotarod test (Figure 2C). These results are the
first to reveal that a single, peripheral injection of hPAP lo-
cally inhibits nociception for an extended period of time
by engaging an A1R-dependent mechanism that is com-
mon to acupuncture.
Since hPAP generates adenosine by dephosphorylating
AMP, we next sought to determine if the magnitude of
the antinociceptive effect could be increased by injecting
additional substrate. To test this possibility, we injected
wild-type mice with hPAP (250 mU) then injected these
same mice with AMP (200 nmol) twenty-four hours
later. AMP injection into the popliteal fossa transiently
boosted the magnitude of the antinociceptive effect only
in mice previously injected with hPAP (Figure 3A,B).
These data indicate that the magnitude of the antinoci-
ceptive effect was dependent on substrate availability.
To determine if the long-lasting antinociceptive effects of
hPAP were due to sustained A1R activation, we next
injected hPAP (250 mU) into the popliteal fossa of wild-
type mice, then 48 h later injected (i.p.) vehicle or a selective
A1R antagonist, 8-cyclopentyl-1,3-dipropylxanthine (CPX).
CPX, but not vehicle, transiently blocked the thermal anti-
nociceptive effect of hPAP for four hours (Figure 3C,D). In
contrast, neither vehicle nor systemic CPX affected thermal
sensitivity in the contralateral (non-hPAP injected) hind-
paw. These data indicate the local antinociceptive effects of
hPAP are due to sustained A1R activation.
We previously found that the antinociceptive effects of
hPAP, when injected intrathecally, were due to A1R acti-
vation and phospholipase C (PLC)-mediated hydrolysis
of phosphatidylinositol 4,5-bisphosphate [14]. To deter-
mine if the antinociceptive effects of PAPupuncture were
PLC-dependent, we injected hPAP (250 mU) then 48 h
later injected vehicle or U73122 (5.4 nmol) into the ipsi-
lateral popliteal fossa. U73122 is commonly used to in-
hibit PLC-dependent signaling. U73122, but not vehicle,
transiently blocked the thermal antinociceptive effect of
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Figure 1 Injection of an A1R agonist into the Weizhong acupuncture point (located within the popliteal fossa) has short-lasting
antinociceptive effects. (A-A’) Cross section of the mouse hind limb cut through knee and popliteal fossa, shows proximity of Weizhong (BL40)
and Zusanli (ST36) acupuncture points to each other and to peripheral nerves. Bones, nerves (n), blood vessels (b), muscle (m) and acupoints
labeled. Tissue stained with PGP9.5 antibody (1:500) to visualize nerves. (B) Noxious thermal and (C) mechanical sensitivity in hindpaw following
injection of CPA (5 nmol) into the popliteal fossa. (D) Noxious thermal and (E) mechanical sensitivity following injection of vehicle into the
popliteal fossa (0.9% saline with 1% DMSO). (B-E) Ipsi = ipsilateral hindpaw. Contra = contralateral hindpaw. Contralateral popliteal fossa was not
injected. Wild-type (n = 10) and A1R
−/− (n = 10) male mice in each cohort. Data are plotted as means ± s.e.m. Paired t-tests were used to compare
responses at each time point to baseline (BL). *P< 0.05, **P< 0.005, ***P< 0.0005.
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http://www.molecularpain.com/8/1/28hPAP for four hours (Figure 3E,F). U73122 alone had no
effect on noxious thermal sensitivity (Figure 3F). Thus,
hPAP inhibits nociception through a PLC-dependent
mechanism when injected peripherally.
We next evaluated whether PAPupuncture could block
hypersensitivity associated with inflammatory pain and
neuropathic pain. To test this, we inflamed one hindpaw
with complete Freund’s adjuvant (CFA) then injected
hPAP (250 mU) one day later into the ipsilateral popliteal
fossa. Strikingly, thermal sensitivity returned to baseline
levels and mechanical sensitivity returned almost to base-
line for three days in wild-type mice but not A1R
−/− mice(Figure 4A,B). Likewise, in the spared nerve injury (SNI)
model of neuropathic pain [27], hPAP (250 mU) inhibited
thermal and mechanical hypersensitivity for three days in
the ipsilateral (injured) hindpaw of wild-type mice but not
A1R
−/− mice (Figure 4C,D). In both chronic pain models,
ipsilateral hPAP injections had no effects in the contralat-
eral (non-inflamed/non-injured) hindpaw (Figure 4A-D).
Collectively, these data indicate that hPAP has localized,
long-lasting, A1R-dependent antinociceptive effects in two
models of chronic pain when injected peripherally.
To determine if peripheral injection of hPAP could pre-
emptively inhibit pain hypersensitivity, as occurs when
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Figure 2 Peripheral injection of PAP into Weizhong acupuncture point (“PAPupuncture”) has localized and long-lasting A1R-dependent
antinociceptive effects. (A) Noxious thermal and (B) mechanical sensitivity following injection of hPAP (250 mU) into the popliteal fossa.
(C) Rotarod tests 24 h before (1 test iteration) and 24 h after (2 test iterations, separated by 40 s) injection of hPAP into the popliteal fossa
(250 mU/mouse). No significant differences in rotarod performance between genotypes or treatment. (A-C) Ipsi = ipsilateral hindpaw.
Contra = contralateral hindpaw. Contralateral popliteal fossa was not injected. Wild-type (n = 10) and A1R
−/− (n = 10) male mice in each cohort.
Data are plotted as means ± s.e.m. Paired t-tests were used to compare responses at each time point to baseline (BL). *P< 0.05, **P< 0.005,
***P< 0.0005.
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http://www.molecularpain.com/8/1/28hPAP is injected intrathecally [14], we injected hPAP
(250 mU) into the popliteal fossa of wild-type and A1R
−/−
mice and performed the SNI surgery the following day.
hPAP reduced nerve-injury induced thermal hyperalgesia
for two days in wild-type but not A1R
−/− mice (Figure 4E).
In addition, injection of hPAP prior to nerve injury
reduced mechanical allodynia for six days in wild-type
mice (Figure 4F), three days longer than when hPAP was
injected after nerve injury (Figure 4D). However, given that
hPAP did not enduringly reduce hyperalgesia and allodynia
for >7 d as hPAP did when injected intrathecally [14], we
conclude that hPAP does not have preemptive antinoci-
ceptive effects when administered peripherally.
There are several possible reasons why hPAP (250 mU)
consistently had antinociceptive effects that lasted three
days but not longer: 1) hPAP depleted the local AMP
pool, 2) A1R desensitized or 3) hPAP protein lost cata-
lytic activity or washed out. To distinguish between these
possibilities, we injected wild-type mice and A1R
−/− mice
with hPAP (250 mU) then injected these same mice with
a second dose (250 mU) three days later. We reasoned
that the second hPAP injection should have no antinoci-
ceptive effects if the first hPAP injection depleted AMP
or desensitized A1R. On the contrary, thermal with-
drawal latency increased in the ipsilateral hindpaw after
the second hPAP injection and remained significantly
elevated for four more days in wild-type mice but not
A1R
−/− mice (Figure 5A). These sequential hPAP injec-
tions did not affect mechanical sensitivity in naïve mice
(Figure 5B). However, sequential hPAP injections
(250 mU on days 21 and 24 post SNI in the ipsilateral
popliteal fossa) had a statistically significant antiallodynic
effect that lasted for five days (data not shown). Thesedata reveal that PAPupuncture duration can be extended
in naïve and sensitized animals by injecting additional
enzyme and that duration is not limited by substrate
availability or A1R desensitization. Unexpectedly, these
results also suggest that the extracellular AMP pool can-
not readily be depleted, perhaps reflective of the fact that
surrounding muscle generates large quantities of ATP
and other nucleotides to power movement.
Since hPAP availability was the limiting factor, we next
hypothesized that larger quantities of hPAP might have
greater and longer-lasting effects on nociception. Indeed,
hPAP dose-dependently inhibited the magnitude and
duration of noxious thermal sensitivity (Figure 5C,D),
with the highest dose (10,000 mU, single injection into
popliteal fossa) lasting for six days—nearly 100x longer
than acupuncture (which lasts up to 1.5 hr, Figure 6A)
[9]. PAPupuncture antinociception was delayed by 1–
6 hr (depending on hPAP dose; Figure 5C), consistent
with hPAP working through an enzymatic process and
not a pharmacological process (contrast with rapid onset
following CPA injection; Figure 1B).
Discussion
While numerous studies indicate that acupuncture is ef-
fective for treating some types of pain, the duration of ac-
tion is limited [1,6-8]. Acupuncture points are located in
muscle in close proximity to peripheral nerves (Figure 1A,
A’) [2], an anatomical location that is ideal for intercepting
pain signals before they reach the brain. Indeed, Goldman
and colleagues found that needle stimulation caused the
localized release of nucleotides and adenosine at acupunc-
ture points followed by short-lasting A1R-dependent anti-
nociceptive effects [9]. Acupuncture also reduced noxious
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Figure 3 Local antinociceptive effects of PAP can be transiently boosted by injecting substrate or transiently blocked by interfering
with A1R signaling. (A) hPAP (250 mU) followed one day later by substrate (200 nmol AMP) were injected into the popliteal fossa. (B) Data from
the boxed area in (A) along with response following injection of AMP (200 nmol) alone into popliteal fossa. (C) hPAP (250 mU) was injected into
the popliteal fossa followed two days later by CPX (1 mg/kg, i.p.). (D) Data from the boxed area in (C). (E) hPAP (250 mU) followed two days later
by U73122 (5.4 nmol) were injected into the ipsilateral popliteal fossa. (F) Data from the boxed area in (E) along with response following injection
of U73122 (5.4 nmol) alone into popliteal fossa. (A-F) Ipsi = ipsilateral hindpaw. Contra = contralateral hindpaw. Contralateral popliteal fossa was
not injected. Wild-type (n = 10) and A1R
−/− (n = 10) male mice in each cohort. Data are plotted as means ± s.e.m. Paired t-tests were used to
compare responses at each time point to BL. *P< 0.05, **P< 0.005, ***P< 0.0005.
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http://www.molecularpain.com/8/1/28stimulus-evoked brain activation [9]. While the localized
actions of acupuncture are, in principle, ideal for treating
pain in specific regions of the body, the short duration of
action leaves much room for improvement. Localized
actions could also reduce or eliminate side-effects asso-
ciated with systemic analgesic drug administration.
PAP can rapidly generate adenosine from AMP and is
endogenously found in nociceptive neurons and in noci-
ceptive axon terminals [10,11]. However, at the time we
began this study, the extent to which PAP or any other
ectonucleotidase was directly involved in adenosine-
dependent antinociceptive mechanisms in the periphery,
including at acupuncture points, was unknown. Depho-
sphorylation of AMP to adenosine is rate limiting in theperiphery and in the brain [9,28], causing extracellular
AMP levels to be basally elevated. As is true for any bio-
chemical process, increasing the concentration of a rate-
limiting enzyme yields more product (in this case adeno-
sine). In light of this information, we hypothesized that
injection of additional hPAP—an enzyme that is en-
dogenously present in muscle tissue surrounding acu-
puncture points [9,12]—could be used to locally generate
adenosine in muscle and near peripheral nerves. Indeed,
injection of hPAP into the Weizhong acupuncture point
had antinociceptive effects that lasted substantially
longer (nearly 100x) than acupuncture (Figure 6A). Our
study is the first to show that PAP inhibits nociception
via an A1R- and PLC-dependent mechanism in the
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Figure 4 PAP has long-lasting, localized antinociceptive effects in chronic inflammatory and neuropathic pain models. (A, B) CFA was
injected into one hindpaw. One day later hPAP (250 mU) was injected into the ipsilateral popliteal fossa. Inflamed and non-inflamed (contralateral)
hindpaws were tested for (A) thermal and (B) mechanical sensitivity. (C, D) The sural and common peroneal branches of the sciatic nerve were
ligated and then transected (injure-arrow). Two days later, hPAP (250 mU) was injected into the ipsilateral popliteal fossa. Injured and non-nerve
injured (contralateral) hindpaws were tested for (C) thermal and (D) mechanical sensitivity. (E, F) Preemptive study. hPAP (250 mU) was injected
into the popliteal fossa. One day later, SNI surgery was performed on the ipsilateral leg. Injured and non-nerve injured (contralateral) hindpaws
were tested for (E) thermal and (F) mechanical sensitivity. (A-F) Ipsi = ipsilateral hindpaw. Contra = contralateral hindpaw. Contralateral popliteal
fossa was not injected. Wild-type (n = 9-10) and A1R
−/− (n = 10) male mice in each cohort. Data are plotted as means ± s.e.m. T-tests were used to
compare responses at each time point between genotypes, same paw comparisons. +P< 0.05, ++P< 0.005, +++P< 0.0005.
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http://www.molecularpain.com/8/1/28periphery (Figure 6B), highlighting a role for this ectonu-
cleotidase in peripheral pain mechanisms.
Given that a selective A1R antagonist blocked the anti-
nociceptive effects of PAPupuncture (CPX, Figure 3), other
compounds that block A1R, such as theophylline and caf-
feine (a non-selective A1 and A2 antagonist), could also re-
duce PAPupuncture efficacy. This possibility could be
particularly relevant if PAPupuncture is advanced into the
clinic, as patients should probably eliminate caffeine (andother xanthine-derived alkaloid) intake to maximize anal-
gesic efficacy. Notably, transcutaneous electrical nerve
stimulation (TENS) is used clinically to reduce the inten-
sity and unpleasantness of pain in humans, and caffeine
(but not placebo) at a dose equivalent to two to three cups
of coffee can block these analgesic effects of TENS [29].
Clinicians inject local anesthetics into the popliteal fossa
to treat pain following foot and ankle surgery. However,
this regional anesthesia procedure requires catheterization
AD
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Figure 5 Larger hPAP doses extend the antinociceptive effects of PAPupuncture. (A) Thermal and (B) mechanical sensitivity following
sequential injections of hPAP (250 mU/injection) into popliteal fossa. (C, D) hPAP dose response. Thermal sensitivity measured in (C) hours and (D)
days post hPAP injection (single injection of the indicated doses). (A-D) Ipsi = ipsilateral hindpaw. Contra = contralateral hindpaw. Contralateral
popliteal fossa was not injected. Wild-type (n = 10) male mice in each cohort. Data are plotted as means ± s.e.m. Paired t-tests were used to
compare responses at each time point to BL. *P< 0.05, **P< 0.005, ***P< 0.0005.
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http://www.molecularpain.com/8/1/28to block pain for more than a day [21,30]. Local nerve
blocks are administered at many other locations of the
body to regionally treat pain. While our work was focused
on the popliteal fossa, PAPupuncture could in principle be
performed in any body region where acupuncture andDuration of antinociception
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http://www.molecularpain.com/8/1/28resistant way to treat pain. Ultimately, our study reveals
that key mechanisms associated with Eastern and Western
medicine can be merged and exploited to locally inhibit
acute and chronic pain for an extended period of time.
Methods
Behavior and injections
All procedures and behavioral experiments involving ver-
tebrate animals were approved by the Institutional Animal
Care and Use Committee at the University of North Caro-
lina at Chapel Hill. All behavior experiments were per-
formed with male mice during the light phase, raised
under a 12:12 light:dark cycle and fed Prolab RMH 3000
(LabDiet) ad libitum. C57BL/6 mice (2–6 months in age)
were purchased from Jackson Laboratories, and A1R
−/−
mice were backcrossed to C57BL/6 J mice for 12 genera-
tions [31]. All mice were acclimated to the experimenter,
the room and the experimental apparatus for 3–5 days
prior to behavioral testing. Thermal sensitivity was moni-
tored using the Hargreaves method, where the radiant heat
source was calibrated to elicit a paw withdrawal reflex of
approximately 10 s in naïve mice (cutoff time of 20 s) as
previously described [10]. Mechanical sensitivity was mea-
sured with semi-flexible tips attached to an electronic Von
Frey apparatus (IITC Life Science).
Unless otherwise specified, all compounds were
injected in a 50 μL volume in 0.5 mL syringes with a 29
gauge, 0.5 inch needle (BD Biosciences) into the popliteal
fossa and diluted in 0.9% saline [32,33]. Mice were
anesthetized with isoflurane (Baxter) prior to injection.
Human prostatic acid phosphatase (hPAP), N6-cyclopen-
tyl adenosine (CPA, 5 nmol in 1% DMSO) and 8-cyclo-
pentyl-1,3-dipropylxanthine (CPX, 1 mg/kg in 0.9%
saline with 5% DMSO and 1.25% 1 M NaOH, injected i.
p., 100 μL) were from Sigma-Aldrich and prepared as
previously described [10]. U73122 (Tocris, 5.4 nmol) was
diluted in 50% DMSO and 50% saline [14]. CFA (20 μL,
MP Biomedicals) was injected under the glabrous skin to
inflame one hindpaw. Spared nerve injury (SNI) was
used to model neuropathic pain [27]. Motor function
was measured by the rotarod performance test (cutoff
time of 300 s). Baseline measurements were collected
with 1 test iteration for each mouse. Trials were again
performed 24 h following injection of hPAP into the
popliteal fossa, with 2 iterations separated by 40 s for
each mouse. Statistical significance was calculated using
Student’s two-tailed t-test. All error bars are shown as
standard error of the mean (± s.e.m.).
Immunohistochemistry
Mice were anesthetized with pentobarbital (50 mg/kg, i.p.)
and perfused intracardially with 4% paraformaldehyde
(PFA, 10 mL) in 0.1 M phosphate buffer (PB), pH 7.4. The
hindlimbs were removed and post-fixed for 24 hr at 4°C in50 mL 4% PFA, washed for 6 h at room temperature in
50 mL PBS and decalcified with 50 mL Rapid Cal Immuno
(BBC Biochemical) for 3 days at 4°C. The tissue was then
cryoprotected in 30% sucrose in PB (50 mL) for 5 days at
4°C before sectioning on the cryostat. Sections of the hind-
limb (40 μm) were thaw-mounted onto slides. PGP 9.5
immunostaining was performed as previously described
[34].
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